Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)
Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)
Recruiting · NCT06958796 · Registry updated 2025-12-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV) | Cytomegalovirus; Kidney Transplant; Complications; Liver Transplant Complications; Organ Transplant; Simultaneous Liver-Kidney Transplantation; Complications | Recruiting | Phase 4 | 2025-12-22 | NCT06958796 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Camille N. Kotton, MD | 1 |
| Kamada, Ltd. | 2 |
| University of Texas Southwestern Medical Center | 295 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Massachusetts General Hospital | Boston | United States | 1015 |
| University of Texas Southwestern | Dallas | United States | 73 |